Central Securities Corp increased its stake in Medtronic PLC by 42.9%, acquiring an additional 75,000 shares to bring its total holding to 250,000 shares, valued at $23.81 million. This makes Medtronic its 22nd largest position, representing 2.0% of the firm’s investment portfolio. Concurrently, Medtronic reported stronger-than-expected quarterly earnings and revenue, providing FY2026 EPS guidance of $5.62–$5.66.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Central Securities Corp Buys 75,000 Shares of Medtronic PLC $MDT
Central Securities Corp increased its stake in Medtronic PLC by 42.9%, acquiring an additional 75,000 shares to bring its total holding to 250,000 shares, valued at $23.81 million. This makes Medtronic its 22nd largest position, representing 2.0% of the firm’s investment portfolio. Concurrently, Medtronic reported stronger-than-expected quarterly earnings and revenue, providing FY2026 EPS guidance of $5.62–$5.66.